Multiple myeloma, or plasma cell myeloma, is a condition in which neoplastic plasma
cells infiltrate the bone marrow and destroy bone.
Multiple myeloma develops slowly and insidiously. The patient often does not manifest
symptoms until the disease is advanced.
Multiple myeloma is seldom cured, but treatment can relieve symptoms, produce
remission, and prolong life. Chemotherapy is usually the first treatment recommended for
Maintaining adequate hydration is a primary nursing consideration to minimize problems
from hypercalcemia. Because of the potential for pathologic fractures, the nurse must be
careful when moving and ambulating the patient.
BLOOD COMPONENT THERAPY
Blood component therapy is frequently used in managing hematologic diseases.
However, blood component therapy only temporarily supports the patient until the
underlying problem is resolved.
When the blood or blood components have been obtained from the blood bank, positive
identification of the donor blood and recipient must be made. Improper product-to-patient
identification causes 90% of hemolytic transfusion reactions.
The blood should be administered as soon as it is brought to the patient. It should not be
refrigerated on the nursing unit.
Autotranfusion, or autologous transfusion, consists of removing whole blood from a
person and transfusing that blood back into the same person. The problems of
incompatibility, allergic reactions, and transmission of disease can be avoided.
A blood transfusion reaction is an adverse reaction to blood transfusion therapy t